Bionano Genomics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-20.8M | $-21.8M | $1.0M | $382.8K |
| FY2018 | $-19.9M | $-20.3M | $331.7K | $1.2M |
| FY2019 | $-29.5M | $-29.6M | $61.1K | $1.3M |
| FY2020 | $-38.3M | $-38.3M | $0 | $1.6M |
| FY2021 | $-71.9M | $-71.9M | — | $9.7M |
| FY2022 | $-124.8M | $-124.8M | — | $22.4M |
| FY2023 | $-125.2M | $-125.2M | — | $15.2M |
| FY2024 | $-68.9M | $-68.9M | — | $9.7M |
| FY2025 | $-16.3M | $-16.3M | — | $4.5M |